The Role of the Microenvironment and Immune System in Regulating Stem Cell Fate in Cancer

Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167 Batlle, 2017, Cancer stem cells revisited, Nat. Med., 23, 1124, 10.1038/nm.4409 Nassar, 2016, Cancer stem cells: basic concepts and therapeutic implications, Annu. Rev. Pathol. Mech. Dis., 11, 47, 10.1146/annurev-pathol-012615-044438 Lytle, 2018, Stem cell fate in cancer growth, progression and therapy resistance, Nat. Rev. Cancer, 18, 669, 10.1038/s41568-018-0056-x Oskarsson, 2014, Metastatic stem cells: sources, niches, and vital pathways, Cell Stem Cell, 14, 306, 10.1016/j.stem.2014.02.002 Clara, 2020, Targeting signalling pathways and the immune microenvironment of cancer stem cells – a clinical update, Nat. Rev. Clin. Oncol., 17, 204, 10.1038/s41571-019-0293-2 Basset-Séguin, 2017, Vismodegib in patients with advanced basal cell carcinoma: primary analysis of STEVIE, an international, open-label trial, Eur. J. Cancer, 86, 334, 10.1016/j.ejca.2017.08.022 Lear, 2018, Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study, J. Eur. Acad. Dermatol. Venereol., 32, 372, 10.1111/jdv.14542 Cortes, 2018, Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: phase 2 study results, Am. J. Hematol., 93, 1301, 10.1002/ajh.25238 Prager, 2019, Cancer stem cells: the architects of the tumor ecosystem, Cell Stem Cell, 24, 41, 10.1016/j.stem.2018.12.009 Plaks, 2015, The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?, Cell Stem Cell, 16, 225, 10.1016/j.stem.2015.02.015 Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Gonzalez, 2018, Roles of the immune system in cancer: from tumor initiation to metastatic progression, Genes Dev., 32, 1267, 10.1101/gad.314617.118 Mantovani, 2017, Tumour-associated macrophages as treatment targets in oncology, Nat. Rev. Clin. Oncol., 14, 399, 10.1038/nrclinonc.2016.217 Aras, 2017, TAMeless traitors: macrophages in cancer progression and metastasis, Br. J. Cancer, 117, 1583, 10.1038/bjc.2017.356 Wu, 2019, Tumor-associated neutrophils in cancer: going pro, Cancers (Basel), 11, 564, 10.3390/cancers11040564 Veglia, 2018, Myeloid-derived suppressor cells coming of age review-article, Nat. Immunol., 19, 108, 10.1038/s41590-017-0022-x Tsou, 2016, The emerging role of b cells in tumor immunity, Cancer Res., 76, 5591, 10.1158/0008-5472.CAN-16-0431 Sica, 2017, Tumor-associated myeloid cells as guiding forces of cancer cell stemness, Cancer Immunol. Immunother., 66, 1025, 10.1007/s00262-017-1997-8 Nywening, 2018, Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma, Gut, 67, 1112, 10.1136/gutjnl-2017-313738 Mitchem, 2013, Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses, Cancer Res., 73, 1128, 10.1158/0008-5472.CAN-12-2731 Calcinotto, 2018, IL-23 secreted by myeloid cells drives castration-resistant prostate cancer, Nature, 559, 363, 10.1038/s41586-018-0266-0 Somasundaram, 2017, Tumor-associated B-cells induce tumor heterogeneity and therapy resistance, Nat. Commun., 8, 607, 10.1038/s41467-017-00452-4 Sharma, 2015, The future of immune checkpoint therapy, Science, 348, 56, 10.1126/science.aaa8172 Kruger, 2019, Advances in cancer immunotherapy 2019 – latest trends, J. Exp. Clin. Cancer Res., 38, 268, 10.1186/s13046-019-1266-0 Wei, 2018, Fundamental mechanisms of immune checkpoint blockade therapy, Cancer Discov., 8, 1069, 10.1158/2159-8290.CD-18-0367 Ribas, 2018, Cancer immunotherapy using checkpoint blockade, Science, 359, 1350, 10.1126/science.aar4060 Sharma, 2017, Primary, adaptive, and acquired resistance to cancer immunotherapy, Cell, 168, 707, 10.1016/j.cell.2017.01.017 Maccalli, 2018, The role of cancer stem cells in the modulation of anti-tumor immune responses, Semin. Cancer Biol., 53, 189, 10.1016/j.semcancer.2018.09.006 Hsu, 2018, STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion, Nat. Commun., 9, 1908, 10.1038/s41467-018-04313-6 Lee, 2016, CD44+ cells in head and neck squamous cell carcinoma suppress T-cell-mediated immunity by selective constitutive and inducible expression of PD-L1, Clin. Cancer Res., 22, 3571, 10.1158/1078-0432.CCR-15-2665 Cioffi, 2015, Cancer therapy: preclinical inhibition of CD47 effectively targets pancreatic cancer stem cells via dual mechanisms, Clin. Cancer Res., 21, 2325, 10.1158/1078-0432.CCR-14-1399 Spranger, 2015, Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity, Nature, 523, 231, 10.1038/nature14404 Miao, 2019, Adaptive immune resistance emerges from tumor-initiating stem cells, Cell, 177, 1172, 10.1016/j.cell.2019.03.025 Lytle, 2019, A multiscale map of the stem cell state in pancreatic adenocarcinoma, Cell, 177, 572, 10.1016/j.cell.2019.03.010 Roberts, 2017, The stromal niche for epithelial stem cells: a template for regeneration and a brake on malignancy, Cancer Cell, 32, 404, 10.1016/j.ccell.2017.08.007 Oudin, 2016, Physical and chemical gradients in the tumor microenvironment regulate tumor cell invasion, migration, and metastasis, Cold Spring Harb. Symp. Quant. Biol., 81, 189, 10.1101/sqb.2016.81.030817 Kalluri, 2016, The biology and function of fibroblasts in cancer, Nat. Rev. Cancer, 16, 582, 10.1038/nrc.2016.73 Valkenburg, 2018, Targeting the tumour stroma to improve cancer therapy, Nat. Rev. Clin. Oncol., 15, 366, 10.1038/s41571-018-0007-1 Gieniec, 2019, Cancer-associated fibroblasts–heroes or villains?, Br. J. Cancer, 121, 293, 10.1038/s41416-019-0509-3 Cazet, 2018, Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer, Nat. Commun., 9, 2897, 10.1038/s41467-018-05220-6 Sansone, 2017, Evolution of cancer stem-like cells in endocrine-resistant metastatic breast cancers is mediated by stromal microvesicles, Cancer Res., 77, 1927, 10.1158/0008-5472.CAN-16-2129 Bartoschek, 2018, Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing, Nat. Commun., 9, 5150, 10.1038/s41467-018-07582-3 Mizutani, 2019, Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis, Cancer Res., 79, 5367, 10.1158/0008-5472.CAN-19-0454 Djurec, 2018, Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors, Proc. Natl. Acad. Sci. U. S. A., 115, E1147, 10.1073/pnas.1717802115 Elyada, 2019, Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts, Cancer Discov., 9, 1102, 10.1158/2159-8290.CD-19-0094 Öhlund, 2017, Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer, J. Exp. Med., 214, 579, 10.1084/jem.20162024 Brechbuhl, 2017, Fibroblast subtypes regulate responsiveness of luminal breast cancer to estrogen, Clin. Cancer Res., 23, 1710, 10.1158/1078-0432.CCR-15-2851 Su, 2018, CD10+GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness, Cell, 172, 841, 10.1016/j.cell.2018.01.009 Cogle, 2016, Acute myeloid leukemia in the vascular niche, Cancer Lett., 380, 552, 10.1016/j.canlet.2015.05.007 Bajaj, 2016, CD98-mediated adhesive signaling enables the establishment and propagation of acute myelogenous leukemia, Cancer Cell, 30, 792, 10.1016/j.ccell.2016.10.003 Zhang, 2018, Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia, Nat. Med., 24, 450, 10.1038/nm.4499 Chaffer, 2011, A perspective on cancer cell metastasis, Science, 331, 1559, 10.1126/science.1203543 Suarez-Carmona, 2017, EMT and inflammation: inseparable actors of cancer progression, Mol. Oncol., 11, 805, 10.1002/1878-0261.12095 Linde, 2018, Macrophages orchestrate breast cancer early dissemination and metastasis, Nat. Commun., 9, 21, 10.1038/s41467-017-02481-5 Talmadge, 2010, AACR centennial series: the biology of cancer metastasis: historical perspective, Cancer Res., 70, 5649, 10.1158/0008-5472.CAN-10-1040 Lee, 2018, Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization, Nat. Commun., 9, 3763, 10.1038/s41467-018-06268-0 Wang, 2017, CXCL1 is critical for premetastatic niche formation and metastasis in colorectal cancer, Cancer Res., 77, 3655, 10.1158/0008-5472.CAN-16-3199 Wculek, 2015, Neutrophils support lung colonization of metastasis-initiating breast cancer cells, Nature, 528, 413, 10.1038/nature16140 De Cock, 2016, Inflammation triggers Zeb1-dependent escape from tumor latency, Cancer Res., 76, 6778, 10.1158/0008-5472.CAN-16-0608 Albrengues, 2018, Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice, Science, 361, 6409, 10.1126/science.aao4227 Agudo, 2018, Quiescent tissue stem cells evade immune surveillance, Immunity, 48, 271, 10.1016/j.immuni.2018.02.001 Turdo, 2019, Meeting the challenge of targeting cancer stem cells, Front. Cell Dev. Biol., 7, 16, 10.3389/fcell.2019.00016 Burr, 2019, An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer, Cancer Cell, 36, 385, 10.1016/j.ccell.2019.08.008 Casey, 2016, MYC regulates the antitumor immune response through CD47 and PD-L1, Science, 352, 227, 10.1126/science.aac9935 Paczulla, 2019, Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion, Nature, 572, 254, 10.1038/s41586-019-1410-1 Mohme, 2017, Circulating and disseminated tumour cells – mechanisms of immune surveillance and escape, Nat. Rev. Clin. Oncol., 14, 155, 10.1038/nrclinonc.2016.144 Wang, 2014, Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells, Cancer Res., 74, 5746, 10.1158/0008-5472.CAN-13-2563 Malladi, 2016, Metastatic latency and immune evasion through autocrine inhibition of WNT, Cell, 165, 45, 10.1016/j.cell.2016.02.025 Kai, 2019, The extracellular matrix modulates the metastatic journey, Dev. Cell, 49, 332, 10.1016/j.devcel.2019.03.026 Labernadie, 2017, A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion, Nat. Cell Biol., 19, 224, 10.1038/ncb3478 Dongre, 2019, New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer, Nat. Rev. Mol. Cell Biol., 20, 69, 10.1038/s41580-018-0080-4 Calon, 2014, TGF-beta in CAF-mediated tumor growth and metastasis, Semin. Cancer Biol., 25, 15, 10.1016/j.semcancer.2013.12.008 Yu, 2014, Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling, Br. J. Cancer, 110, 724, 10.1038/bjc.2013.768 Zhuang, 2015, TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT, Sci. Rep., 5, 11924, 10.1038/srep11924 Ebbing, 2019, Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma, Proc. Natl. Acad. Sci. U. S. A., 116, 2237, 10.1073/pnas.1820459116 Waghray, 2016, GM-CSF mediates mesenchymal–epithelial cross-talk in pancreatic cancer, Cancer Discov., 6, 886, 10.1158/2159-8290.CD-15-0947 Ao, 2015, Identification of cancer-associated fibroblasts in circulating blood from patients with metastatic breast cancer, Cancer Res., 75, 4681, 10.1158/0008-5472.CAN-15-1633 Massagué, 2016, Metastatic colonization by circulating tumour cells, Nature, 529, 298, 10.1038/nature17038 Celià-Terrassa, 2018, Metastatic niche functions and therapeutic opportunities, Nat. Cell Biol., 20, 868, 10.1038/s41556-018-0145-9 Esposito, 2019, Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis, Nat. Cell Biol., 21, 627, 10.1038/s41556-019-0309-2 Goddard, 2018, Dormant tumour cells, their niches and the influence of immunity, Nat. Cell Biol., 20, 1240, 10.1038/s41556-018-0214-0 Gao, 2016, Multi-organ site metastatic reactivation mediated by non-canonical discoidin domain receptor 1 signaling, Cell, 166, 47, 10.1016/j.cell.2016.06.009 Sansone, 2017, Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer, Proc. Natl. Acad. Sci. U. S. A., 114, E9066, 10.1073/pnas.1704862114 Fabian, 2019, Metastasis of pancreatic cancer: an uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells, Cancer Lett., 453, 95, 10.1016/j.canlet.2019.03.039 Carlson, 2019, Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy, Nat. Cell Biol., 21, 238, 10.1038/s41556-018-0267-0 Drost, 2018, Organoids in cancer research, Nat. Rev. Cancer, 18, 407, 10.1038/s41568-018-0007-6 Aboulkheyr Es, 2018, Personalized cancer medicine: an organoid approach, Trends Biotechnol., 36, 358, 10.1016/j.tibtech.2017.12.005 Brancato, 2020, Could 3D models of cancer enhance drug screening?, Biomaterials, 232, 119744, 10.1016/j.biomaterials.2019.119744 Rodrigues, 2018, Emerging tumor spheroids technologies for 3D in vitro cancer modeling, Pharmacol. Ther., 184, 201, 10.1016/j.pharmthera.2017.10.018 Spinler, 2020, A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia, Nat. Commun., 11, 5998, 10.1038/s41467-020-19782-x Fox, 2016, Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma, Nature, 534.7607, 407, 10.1038/nature17988 Ellenbroek, 2014, Imaging hallmarks of cancer in living mice, Nat. Rev. Cancer, 14, 406, 10.1038/nrc3742 Dierks, 2008, Expansion of Bcr-Abl-positive leukemic stem cells Is dependent on Hedgehog pathway activation, Cancer Cell, 14, 238, 10.1016/j.ccr.2008.08.003 Zhao, 2009, Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia, Nature, 458, 776, 10.1038/nature07737